Vaborbactam

N/A

Report date: 2025/02/18 20:00:04
NME

Base Information

Drug NameVaborbactam
Drug Alias NameVaborbactamum法硼巴坦伐波巴坦韦博巴坦RPX-7009 +[6] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBeta Lactamase inhibitors
TargetsBeta Lactamase
Therapy Area/IndicationsGram-Negative Bacterial InfectionsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesPoland +[7] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMelinta Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesMenarini Group
Inactive CompaniesRempex Pharmaceuticals Inc
Active IndicationsGram-Negative Bacterial Infections
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A